Printer Friendly

FDA approves Internal Fixation Systems subtalar implants.

M2 PHARMA-January 24, 2012-FDA approves Internal Fixation Systems subtalar implants(C)2012 M2 COMMUNICATIONS

24 January 2012 - Internal Fixation Systems (OTCBB:IFIX), a US-based producer of orthopaedics implants, said on Monday that it has received clearance from the US Food and Drug Administration (FDA) to market its subtalar implants in the US.

These implants allow patients suffering from trauma or arthritis to preserve motion at their ankle joints.

IFS currently offers a full line of mini-cannulated screws for small bone fixation as well as a Modular Locking Small Fragment System for treatment of bone fractures and osteotomies.

((Comments on this story may be sent to info@m2.com)).END.PUB430>PDJanuary 24, 2012>JNM2 PHARMA.PRICEDATENOT APPLICABLE.DAY

COPYRIGHT 2012 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Jan 24, 2012
Words:118
Previous Article:US court rules against J&J in stent patents lawsuit.
Next Article:FDA approves label change for VELCADE.
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |